The role of exercise-induced hormone irisin in amyloid beta reduction

Researchers explored the biological mechanisms by which exercise-induced irisin attenuates amyloid-beta pathology in Alzheimer’s disease.

Sandoz pays out $265M to settle part of antitrust lawsuit

Sandoz and its subsidiary Fougera Pharmaceuticals have agreed to shell out $265 million in an antitrust case brought against them in Pennsylvania’s eastern district. In

March 1, 2024

It’s Getting Harder for Rural Pharmacies to Stay Afloat

Basin Pharmacy fills more than prescriptions in rural northern Wyoming. It’s also the key healthcare access point for the town of about 1,300 people and

June 9, 2024

Genentech and Sangamo to develop new therapies

The collaboration focuses on intravenously administered treatments targeting the tau gene, associated with Alzheimer’s disease and other tauopathies. Credit: Milad Fakurian on Unsplash. Sangamo Therapeutics

August 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.